Post

New research · Ophthalmology
Journal of applied clinical medical physics · 15h
StudyJournal of applied clinical medical physics · 2025

Feasibility of treatment planning with HyperArc stereotactic radiosurgery methods for ocular tumors.

Chase Cochran, Shane McCarthy, William St Clair, Damodar Pokhrel
Read paper
OphthalmologyStudy

HyperArc stereotactic radiosurgery kept optic nerve dose significantly below the safety threshold.

Feasibility of treatment planning with HyperArc stereotactic radiosurgery methods for ocular tumors.

Chase Cochran … Damodar Pokhrel
Journal of applied clinical medical physics · 2025
Background

Various stereotactic radiosurgery (stereotactic radiosurgery) platforms have also been employed, yet widespread access remains a challenge.

Purpose

Currently, ocular disease is primarily managed with COMS plaque brachytherapy.

Methods

Twenty previously treated COMS patients with ocular melanoma were selected for a retrospective HyperArc stereotactic radiosurgery planning study.

Results

optic nerve radiation stayed well below the safety limit

HyTEC standard
12.1Gy
HyperArc optic nerve D
7.18Gy
More results

HyperArc plans demonstrated high conformality Paddick conformity index (PCI = 0.84 ± 0.04) with steep dose gradient index (GI = 3.29 ± 0.38).

Adequate planning target volumes coverage (D99% = 23.80 ± 0.46 Gy) was achieved with a mean gross tumor volume dose of 27.54 ± 0.47 Gy.

Average beam-on time was under 9 min.

More results

End-to-end quality assurance results showed a 99.00 ± 0.59% pass rate (2%/2 mm γ-criteria), with a Monte Carlo check showing 97.81 ± 1.24% agreement with the AcurosXB algorithm (2%/2 mm).

“
Conclusion · 1 of 2

HyperArc stereotactic radiosurgery plans provided adequate target coverage, acceptable organs at risk sparing, and offer a fast, safe, and non-invasive treatment option for ocular tumors.

Conclusion · 2 of 2

Clinical implementation of this novel methodology is ongoing at our institution.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment